| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002914A1 Modified proteins |
| 01/20/2000 | WO2000002912A2 Disintegrin homologs |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002910A2 Human fast-1 gene |
| 01/20/2000 | WO2000002909A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 01/20/2000 | WO2000002907A1 Tumor antigen peptide originating in sart-1 |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO2000002899A1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002893A1 Metal ion-binding mass markers for nucleic acids |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002581A1 Antigenic peptides derived from telomerase |
| 01/20/2000 | WO2000002520A2 T-lymphocyte exchange |
| 01/20/2000 | WO1999060408A3 Assay involving protein binding to 3' untranslated mrna sequences |
| 01/20/2000 | WO1999060138A3 Regulated expression of pkc and/or srb1/psa1 in yeast |
| 01/20/2000 | WO1999060117A3 Prax-1 polypeptide |
| 01/20/2000 | WO1999060007A3 Libraries of oligomers labelled with different tags |
| 01/20/2000 | WO1999059633A8 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 01/20/2000 | WO1999058690A3 Nucleic acid molecules which code for enzymes derived from wheat and which are involved in the synthesis of starch |
| 01/20/2000 | WO1999058676A3 Semaphorin polypeptides |
| 01/20/2000 | WO1999058659A3 Methods and compositions for expression of transgenes in plants |
| 01/20/2000 | WO1999058652A3 Cytotoxin-based biological containment |
| 01/20/2000 | WO1999058641A8 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/20/2000 | WO1999058559A3 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 01/20/2000 | WO1999058544A9 Hybrid anthracyclines from genetically engineered streptomyces galilaeus strains |
| 01/20/2000 | WO1999057273A3 Cytoplasmic antiproteinase-3 coding sequence in gene therapy |
| 01/20/2000 | WO1999057145A3 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 01/20/2000 | WO1999055913A3 Reduced complexity nucleic acid targets and methods of using same |
| 01/20/2000 | WO1999055851A3 Site-directed transformation of plants |
| 01/20/2000 | WO1999053067A8 Seed-coat promoters, genes and gene products |
| 01/20/2000 | WO1999053052A3 Srebp-2-deficient cell lines |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | WO1999049037A3 Protein phosphatase-related molecules |
| 01/20/2000 | WO1999049035A3 Insecticidal compounds from segestria florentina |
| 01/20/2000 | WO1999048916A3 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/20/2000 | WO1999048897B1 Synthesis of compounds and libraries of compounds |
| 01/20/2000 | WO1999047674A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/20/2000 | WO1999046288A3 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 01/20/2000 | WO1999042091A3 Use of polycations as endosomolytic agents |
| 01/20/2000 | WO1999041386A3 Novel endo-xylogalacturonase |
| 01/20/2000 | WO1999040115A9 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
| 01/20/2000 | WO1999038964A3 Promoter regions of the mouse and human telomerase rna component genes |
| 01/20/2000 | DE19932908A1 Bacillus genes for synthesis of anticapsin and bacilysine are useful as antagonists of glucosamine synthesis |
| 01/20/2000 | DE19932811A1 Recombinant haploid or diploid Yarrowia lipolytica for functional heterologous expression of cytochrome P450 systems |
| 01/20/2000 | DE19921676A1 Aminosäuresequenz Amino acid sequence |
| 01/20/2000 | DE19832334A1 Use of a glucosylglycerol phosphate synthase gene for glucosylglycerol production and generation of transgenic plants with increased tolerance against environmental stress |
| 01/20/2000 | DE19831420A1 Chimeric promoter constructs with binding sites for recombinant transcription factors useful for producing agents to treat cancer, inflammation, allergy and autoimmune diseases |
| 01/20/2000 | DE19831312A1 Transgenic mice useful for controlled in vivo cell ablation through recombinase activated expression of cell death inducible genes |
| 01/20/2000 | CA2748996A1 Antigenic peptides derived from telomerase |
| 01/20/2000 | CA2385962A1 Metal ion-binding mass markers for nucleic acids |
| 01/20/2000 | CA2337685A1 Modified proteins |
| 01/20/2000 | CA2337680A1 Polyester analogue of poly-l-lysine as a soluble, biodegradable gene delivery carrier |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2336805A1 Pharmaceutical uses of nab1 and nab2 |
| 01/20/2000 | CA2336710A1 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 01/20/2000 | CA2335382A1 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 01/20/2000 | CA2335272A1 Mouse growth hormone secretagogue receptor |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2334160A1 Method for producing a peptide with a pi above 8 or below 5 |
| 01/20/2000 | CA2334079A1 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use |
| 01/20/2000 | CA2334078A1 Lupus anticoagulant antibody to f1 region of prothrombin |
| 01/20/2000 | CA2334043A1 Antibiotic protein and method of production |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2333891A1 Conditional mutants of influenza virus m2 protein |
| 01/20/2000 | CA2333857A1 Growth hormone secretagogue related receptors and nucleic acids |
| 01/20/2000 | CA2333855A1 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 01/20/2000 | CA2333308A1 Enhancer elements for increased translation in plant plastids |
| 01/20/2000 | CA2333148A1 Expression of eukaryotic peptides in plant plastids |
| 01/20/2000 | CA2332700A1 Expression of herbicide tolerance genes in plant plastids |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332568A1 Tumor antigen peptide originating in sart-1 |
| 01/20/2000 | CA2332497A1 Presenilin 2 specific ribozyme |
| 01/20/2000 | CA2332346A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | CA2332344A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | CA2332311A1 Disintegrin homologs |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/19/2000 | EP0972848A2 Self-quenching fluorescence probe and method |
| 01/19/2000 | EP0972841A1 Display of viral proteins as ligands for cell-surface receptor |
| 01/19/2000 | EP0972840A2 New attenuated myxoma recombinant virus and its use in the preparation of mixed vaccines against myxomatosis and rabbit hemorrhagic disease |
| 01/19/2000 | EP0972839A1 Insertional mutations in mycobacteria |
| 01/19/2000 | EP0972838A1 Escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972836A2 Endonuclease |
| 01/19/2000 | EP0972835A1 Propionibacterium vector |
| 01/19/2000 | EP0972834A1 Induction promoter gene and secretory signal gene usable in schizosaccharomyces pombe, expression vectors having the same, and use thereof |
| 01/19/2000 | EP0972833A1 PROBES FOR THE DIAGNOSIS OF INFECTIONS CAUSED BY $i(KLEBSIELLA PNEUMONIAE) |
| 01/19/2000 | EP0972832A1 New gene with reduced expression in metastatic human melanoma cells and the protein coded thereby, methods of production and use thereof |
| 01/19/2000 | EP0972831A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 01/19/2000 | EP0972829A1 Knockout animals |
| 01/19/2000 | EP0972782A1 Monoclonal antibody which recognizes the oligosaccharide n-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 01/19/2000 | EP0972780A1 Il-6 antagonist peptides |
| 01/19/2000 | EP0972564A2 Combinatorial strategies for polymer synthesis |
| 01/19/2000 | EP0972524A1 Lymphocyte activation inhibitors |
| 01/19/2000 | EP0972523A2 Method and compositions for inducing immunity to viruses |
| 01/19/2000 | EP0972518A2 Exchange of T lymphocytes |
| 01/19/2000 | EP0972445A1 Pluripotent cells having disrupted intrinsic genes |
| 01/19/2000 | EP0972201A2 Compounds for immunodiagnosis of prostate cancer and methods for their use |